Pancreatic cancer

Pancreatic cancer (also called cancer of the pancreas) is represented by the growth of a malignant tumour within the small pancreas organ. Each year about 31,000 individuals in the United States are diagnosed with this condition, with more than 60,000 in Europe.

New method can diagnose pancreatic cancer with 97% certainty

Researchers at The Sahlgrenska Academy have now developed a method which identifies the Pancreatic cancer’s visible precursors with 97% certainty – Pancreatic cancer is often detected at a late stage, which results in poor prognosis and limited treatment options. Researchers at The Sahlgrenska Academy have now developed a method which identifies the cancer’s visible precursors with 97% certainty.

Smoking, heavy drinking linked to pancreatic cancer risk

Smoking, heavy drinking linked to earlier onset of pancreatic cancer — University of Michigan Health System study makes step toward learning when cancer screenings should start – Those who smoke and drink heavily may develop pancreatic cancer at an earlier age than those who don’t. In a recent study, published in the American Journal of Gastroenterology, heavy smokers with pancreatic cancer were diagnosed around age 62 and heavy drinkers at age 61 ? almost a decade earlier than the average age of 72.

Pancreatic cancer risk lowers with high sun exposure

Sun exposure and sun-sensitive skin type decreased risk for pancreatic cancer – High levels of ultraviolet radiation at an individual’s birth location, sun-sensitive skin type and a history of skin cancer each decreased risk for pancreatic cancer, according to Australian researchers.

Breast cancer vaccine reduces tumours in mice

Scientists develop vaccine that attacks breast cancer in mice — Implications for the treatment of ovarian, colorectal and pancreatic cancer, as well – Researchers have developed a vaccine that dramatically reduces tumors in a mouse model that mimics 90 percent of human breast and pancreatic cancer cases-including those that are resistant to common treatments.

Gene is mutated in 1 in 3 patients with kidney cancer

Research provides new kidney cancer clues — Gene is mutated in 1 in 3 patients with common form of renal cancer – Researchers have identified a gene that is mutated in one in three patients with the most common form of renal cancer. The identification of a frequently mutated gene will provide new insights into the biology of the disease.

A new way to test blood for Alzheimer’s disease

A blood test for Alzheimer’s disease? – Using a new technology that relies on thousands of synthetic molecules to fish for disease-specific antibodies, researchers have developed a potential method for detecting Alzheimer’s disease with a simple blood test.

Pancreatic cancers progress to lethal stage slowly

Surprise finding: Pancreatic cancers progress to lethal stage slowly – Pancreatic cancer develops and spreads much more slowly than scientists have thought, according to new research from Johns Hopkins investigators.

New drug reverses resistance to chemotherapy in pancreatic cancer patients

Pancreatic cancer: Researchers find drug that reverses resistance to chemotherapy – For the first time researchers have shown that by inhibiting the action of an enzyme called TAK-1, it is possible to make pancreatic cancer cells sensitive to chemotherapy, opening the way for the development of a new drug to treat the disease.

Eurand’s Zenpep pancreatic enzyme product approved by FDA

Eurand Granted FDA Approval for ZENPEP(TM) — First and Only FDA-Approved Pancreatic Enzyme Product Clinically Tested in Patients Under 12 Years Old. – U.S. Food and Drug Administration (FDA) has approved Eurand’s New Drug Application (NDA) for ZENPEP(TM) (pancrelipase) Delayed-Release Capsules for the treatment of exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis (CF) or other conditions.